Fresenius Medical Care KGAA ST (FMEd)

BATS Europe


	Symbol		Exchange		Currency
	FMEG		Derived		EUR	Real-time
	FMEG		Xetra		EUR	Delayed
	FMEd		BATS Europe		EUR	Delayed
	FMS		NYSE		USD	Real-time
	0H9X		London		EUR	Real-time
	FMEG		Milan		EUR	Real-time
	FMEG		TradeGate		EUR	Delayed
	FMEG		Frankfurt		EUR	Delayed
	FMEG		Vienna		EUR	Real-time

Currency in EUR

44.51

0.00(0.00%)

Closed04/12

Fair Value

Day's Range

44.51

44.51

52 wk Range

32.81

44.51

FMEd Income Statement

Featured here, the Income Statement (earnings report) for Fresenius Medical Care KGAA ST, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

17,476.56

17,859.06

17,618.69

19,398.02

19,453.62

Total Revenues Growth

+5.62%

+2.19%

-1.35%

+10.1%

+0.29%

Cost Of Revenues

12,080.7

12,321.62

12,845.66

14,504.33

14,528.61

Gross Profit

5,395.85

5,537.45

4,773.03

4,893.69

4,925.01

Gross Profit Growth

+4.68%

+2.62%

-13.8%

+2.53%

+0.64%

Gross Profit Margin %

30.87%

31.01%

27.09%

25.23%

25.32%

Other Operating Expenses, Total

3,112.3

3,159.74

2,869.2

3,355.74

3,401.44

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+4.76%	+1.52%	-9.19%	+16.96%	+1.36%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	168.03	193.77	220.78	228.62	231.97
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,944.27	2,965.96	2,772.83	3,170.37	3,196.34
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-124.41	-43.25	-26.86

Operating Income

2,283.55

2,377.71

1,903.83

1,537.95

1,523.56

Operating Income Growth

+4.57%

+4.12%

-19.93%

-19.22%

-0.94%

EBIT Margin %

13.07%

13.31%

10.81%

7.93%

7.83%

Net Interest Expenses

-429.44

-368.02

-280.43

-292.48

-336.42

Net Interest Expenses Growth

-42.64%

+14.3%

+23.8%

-4.3%

-15.03%

Interest Expense, Total

-491.06

-409.98

-353.6

-360.14

-424.64

Interest And Investment Income

61.62

41.96

73.17

67.66

88.22

Other Non Operating Expenses, Total

73.68

94.52

82.28

29.73

86.29

EBT, Excl. Unusual Items

1,927.79

2,104.21

1,705.67

1,275.2

1,273.43

Gain (Loss) On Sale Of Assets

-

-

-8.63

47.17

4.84

Other Unusual Items, Total

4.02

26.16

-

-

-

EBT, Incl. Unusual Items

1,840.11

1,936.39

1,571.86

1,219.28

1,033.02

EBT, Incl. Unusual Items Growth

-32.76%

+5.23%

-18.83%

-22.43%

-15.28%

EBT, Incl. Unusual Items Margin

10.53%

10.84%

8.92%

6.29%

5.31%

Income Tax Expense

401.61

500.56

352.83

324.95

300.56

Net Income to Company

1,438.5

1,435.83

1,219.03

894.33

732.46

Minority Interest

-238.88

-271.46

-249.72

-220.92

-233.46

Net Income

1,199.62

1,164.38

969.31

673.41

499

Net Income Growth

-39.47%

-2.94%

-16.75%

-30.53%

-25.9%

Net Income Margin %

6.86%

6.52%

5.5%

3.47%

2.57%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

1,199.62

1,164.38

969.31

673.41

499

Basic EPS - Continuing Operations

3.96

3.96

3.31

2.3

1.7

Basic EPS - Continuing Operations Growth

-38.7%

-0.09%

-16.44%

-30.6%

-25.94%

Diluted EPS - Continuing Operations

3.96

3.96

3.31

2.3

1.7

Diluted EPS - Continuing Operations Growth

-38.6%

-0.01%

-16.44%

-30.6%

-25.97%

Basic Weighted Average Shares Outstanding

302.69

294.06

292.94

293.25

293.41

Diluted Weighted Average Shares Outstanding

302.75

294.28

293.07

293.25

293.41

Dividend Per Share

1.2

1.34

1.35

1.12

1.19

Dividend Per Share Growth

+2.56%

+11.67%

+0.75%

-17.04%

+6.25%

EBITDA

3,136.68

3,260.58

2,798.72

2,449.76

2,379.14

EBITDA Growth

+7.84%

+3.95%

-14.16%

-12.47%

-2.88%

EBITDA Margin %